Ventria Bioscience   Report issue

For profit Phase 3
Founded: Junction City KS United States (1993)
Status: Left NME R&D (2022)

Organization Overview

First Clinical Trial
2005
NCT00377078
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2017

Timeline

NOW
  • Now

Active Ingredients

Drugs in Phase 3 Trials (1)

lactoferrin (4 trials)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Diarrhea (Phase 3)

HIV Infections (Phase 2)

Inflammation (Phase 2)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 4
  • # of Trial APIs: 1